Tag | Content |
---|---|
UniProt Accession | ITB1_HUMAN; P05556; |
Entrez ID | 3688 |
GenBank Protein ID | NM_002211.3; NM_033668.2; NM_133376.2; |
GenBank Nucleotide ID | NP_002202.2; NP_391988.1; NP_596867.1; |
Protein Name | Integrin beta-1 (Fibronectin receptor subunit beta) (Glycoprotein IIa) (GPIIA) (VLA-4 subunit beta) (CD antigen CD29) |
Gene Name | ITGB1; FNRB; MDF2; MSK12 |
Organism | Homo sapiens |
NCBI Taxa ID | 9606 |
Functional Description | Integrins alpha-1/beta-1, alpha-2/beta-1, alpha-10/beta-1 and alpha-11/beta-1 are receptors for collagen. Integrins alpha-1/beta-1 and alpha-2/beta-2 recognize the proline-hydroxylated sequence G-F-P-G-E-R in collagen. Integrins alpha-2/beta-1, alpha-3/beta-1, alpha-4/beta-1, alpha-5/beta-1, alpha-8/beta-1, alpha-10/beta-1, alpha-11/beta-1 and alpha-V/beta-1 are receptors for fibronectin. Alpha-4/beta-1 recognizes one or more domains within the alternatively spliced CS-1 and CS-5 regions of fibronectin. Integrin alpha-5/beta-1 is a receptor for(view all) |
Sequence (Fasta) | MNLQPIFWIG LISSVCCVFA QTDENRCLKA NAKSCGECIQ AGPNCGWCTN STFLQEGMPT 60 SARCDDLEAL KKKGCPPDDI ENPRGSKDIK KNKNVTNRSK GTAEKLKPED ITQIQPQQLV 120 LRLRSGEPQT FTLKFKRAED YPIDLYYLMD LSYSMKDDLE NVKSLGTDLM NEMRRITSDF 180 RIGFGSFVEK TVMPYISTTP AKLRNPCTSE QNCTSPFSYK NVLSLTNKGE VFNELVGKQR 240 ISGNLDSPEG GFDAIMQVAV CGSLIGWRNV TRLLVFSTDA GFHFAGDGKL GGIVLPNDGQ 300 CHLENNMYTM SHYYDYPSIA HLVQKLSENN IQTIFAVTEE FQPVYKELKN LIPKSAVGTL 360 SANSSNVIQL IIDAYNSLSS EVILENGKLS EGVTISYKSY CKNGVNGTGE NGRKCSNISI 420 GDEVQFEISI TSNKCPKKDS DSFKIRPLGF TEEVEVILQY ICECECQSEG IPESPKCHEG 480 NGTFECGACR CNEGRVGRHC ECSTDEVNSE DMDAYCRKEN SSEICSNNGE CVCGQCVCRK 540 RDNTNEIYSG KFCECDNFNC DRSNGLICGG NGVCKCRVCE CNPNYTGSAC DCSLDTSTCE 600 ASNGQICNGR GICECGVCKC TDPKFQGQTC EMCQTCLGVC AEHKECVQCR AFNKGEKKDT 660 CTQECSYFNI TKVESRDKLP QPVQPDPVSH CKEKDVDDCW FYFTYSVNGN NEVMVHVVEN 720 PECPTGPDII PIVAGVVAGI VLIGLALLLI WKLLMIIHDR REFAKFEKEK MNAKWDTGEN 780 PIYKSAVTTV VNPKYEGK 799 |
|
Database | Annotation |
---|---|
CTD (Curated) (count: 11) (view all) | MESH:D002114
; Calcinosis MESH:D002294 ; Carcinoma, Squamous Cell MESH:D009202 ; Cardiomyopathies MESH:D002311 ; Cardiomyopathy, Dilated MESH:D004715 ; Endometriosis MESH:D005911 ; Gliosis |
DisGeNet (Curated) (count: 11) (view all) | C0006663; Calcinosis
C0007131; Non-Small Cell Lung Carcinoma C0007137; Squamous cell carcinoma C0007193; Cardiomyopathy, Dilated C0014175; Endometriosis C0017639; Gliosis |
GWASdb (count: 7) (view all) | rs10508776; Suicide attempts in bipolar disorder; bipolar disorder
rs2153875; Cognitive impairment induced by topiramate; cognitive disorder rs4587680; White matter integrity; bipolar disorder|brain disease rs2488326; Salmonella-induced pyroptosis; Null rs2230396; Salmonella-induced pyroptosis; Null rs9417094; Multiple complex diseases; Null |
PTM | Modification Sites |
---|---|
Phosphorylation (count: 20) (view all) | 13 IFWIGLISSVCCVFA dbPAF
130 LRSGEPQTFTLKFKR dbPAF 14 FWIGLISSVCCVFAQ dbPAF 141 KFKRAEDYPIDLYYL dbPAF 147 DYPIDLYYLMDLSYS dbPAF 186 DFRIGFGSFVEKTVM dbPAF |
Acetylation (count: 4) | 619 ICECGVCKCTDPKFQ PLMD
678 TKVESRDKLPQPVQP PLMD 774 EKEKMNAKWDTGENP PLMD 794 VTTVVNPKYEGK*** PLMD |
Ubiquitination (count: 23) (view all) | 107 KGTAEKLKPEDITQI PLMD
134 EPQTFTLKFKRAEDY PLMD 163 KDDLENVKSLGTDLM PLMD 190 GFGSFVEKTVMPYIS PLMD 202 YISTTPAKLRNPCTS PLMD 228 NVLSLTNKGEVFNEL PLMD |
Sumoylation (count: 3) | 774 EKEKMNAKWDTGENP PLMD
784 TGENPIYKSAVTTVV PLMD 794 VTTVVNPKYEGK*** PLMD |
Malonylation (count: 1) | 794 VTTVVNPKYEGK*** PLMD |
Network | Interaction | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
A | B | Source | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|